1.Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
Ji-Jung JUNG ; Jong-Ho CHEUN ; Soo-Yeon KIM ; Jiwon KOH ; Jai Min RYU ; Tae-Kyung YOO ; Hee-Chul SHIN ; Sung Gwe AHN ; Seho PARK ; Woosung LIM ; Sang-Eun NAM ; Min Ho PARK ; Ku Sang KIM ; Taewoo KANG ; Jeeyeon LEE ; Hyun Jo YOUN ; Yoo Seok KIM ; Chang Ik YOON ; Hong-Kyu KIM ; Hyeong-Gon MOON ; Wonshik HAN ; Nariya CHO ; Min Kyoon KIM ; Han-Byoel LEE
Journal of Breast Cancer 2024;27(1):61-71
		                        		
		                        			 Purpose:
		                        			Advances in chemotherapeutic and targeted agents have increased pathologic complete response (pCR) rates after neoadjuvant systemic therapy (NST). Vacuum-assisted biopsy (VAB) has been suggested to accurately evaluate pCR. This study aims to confirm the non-inferiority of the 5-year disease-free survival of patients who omitted breast surgery when predicted to have a pCR based on breast magnetic resonance imaging (MRI) and VAB after NST, compared with patients with a pCR who had undergone breast surgery in previous studies. 
		                        		
		                        			Methods
		                        			The Omission of breast surgery for PredicTed pCR patients wIth MRI and vacuumassisted bIopsy in breaST cancer after neoadjuvant systemic therapy (OPTIMIST) trial is a prospective, multicenter, single-arm, non-inferiority study enrolling in 17 tertiary care hospitals in the Republic of Korea. Eligible patients must have a clip marker placed in the tumor and meet the MRI criteria suggesting complete clinical response (post-NST MRI size ≤ 1 cm and lesion-to-background signal enhancement ratio ≤ 1.6) after NST. Patients will undergo VAB, and breast surgery will be omitted for those with no residual tumor. Axillary surgery can also be omitted if the patient was clinically node-negative before and after NST and met the stringent criteria of MRI size ≤ 0.5 cm. Survival and efficacy outcomes are evaluated over five years.Discussion: This study seeks to establish evidence for the safe omission of breast surgery in exceptional responders to NST while minimizing patient burden. The trial will address concerns about potential undertreatment due to false-negative results and recurrence as well as improved patient-reported quality of life issues from the omission of surgery. Successful completion of this trial may reshape clinical practice for certain breast cancer subtypes and lead to a safe and less invasive approach for selected patients. 
		                        		
		                        		
		                        		
		                        	
2.Pancreatic metastasis from papillary thyroid cancer: a case report and literature review
Sang Hwa SONG ; Young Hoe HUR ; Chol Kyoon CHO ; Yang Seok KOH ; Eun Kyu PARK ; Hee Joon KIM ; Sang Hoon SHIN ; Sung Yeol YU ; Chae Yung OH
Korean Journal of Clinical Oncology 2023;19(1):32-37
		                        		
		                        			
		                        			 Pancreatic metastasis from papillary thyroid cancer (PTC) is extremely rare; only 18 cases have been reported in the literature. However, several reviews have highlighted similar characteristics between metastatic and primary pancreatic tumors. The patient was a 51-year-old male with a history of total thyroidectomy, modified radical neck dissection, and radioactive iodine ablation for PTC in 2014. Nodules suspected of metastasis were found in both lungs on chest computed tomography (CT). However, after 6 months, a follow-up chest CT showed no increase in size; thus, a follow-up observation was planned. Six years after his initial diagnosis, abdominal CT and pancreas magnetic resonance imaging revealed a 4.7 cm cystic mass with a 2.5 cm enhancing mural nodule in the pancreas tail. We diagnosed the pancreatic lesion as either metastatic cancer or primary pancreas cancer. The patient underwent distal pancreato-splenectomy. After surgery, the pathological report revealed that the mass was metastatic PTC. Pancreatic metastasis from PTC indicates an advanced tumor stage and poor prognosis. However, pancreatectomy can increase the survival rate when the lesion is completely resectable. Therefore, surgical resection should be considered as a treatment for pancreatic metastasis from PTC. 
		                        		
		                        		
		                        		
		                        	
3.Factors predicting injury severity in driver traffic accidents
Chul-Hwan PARK ; Sung-Wook PARK ; Seok-Ran YEOM ; Soon Chang PARK ; Youngmo CHO ; Byung Kwan BAE ; Sang Kyoon HAN
Journal of the Korean Society of Emergency Medicine 2022;33(1):37-44
		                        		
		                        			 Objective:
		                        			The factors related to injury severity in accidents in Korea are unclear. This study helps primary physicians treat victims of traffic accidents with a high probability of severe injury during the initial evaluation in the emergency department (ED). 
		                        		
		                        			Methods:
		                        			This study was conducted on patients who visited Pusan National University Hospital regional trauma center, Korea, between January 2017 and December 2019 due to involvement in automobile accidents as a driver. Multivariate logistic regression analysis was used to determine the relationship of factors with injury severity. 
		                        		
		                        			Results:
		                        			A total of 973 patients were included. Of them, 316 (32.5%) were severely injured. In the multivariate logistic regression analysis, older age was significantly associated with more severe injury (odds ratio [OR], 1.030; 95% confidence interval [CI], 1.017-1.043; P<0.001). A significant difference was noted in injury severity according to the mode of transportation to the ED. Transportation via private ambulance was associated with more severe injury than via public ambulance (OR, 5.853; 95% CI, 3.986-8.594; P<0.001). The severe injury was more likely when the collision involved a large-sized vehicle (OR, 2.369; 95% CI, 1.466-3.826; P<0.001), or a fixed object (OR, 2.077; 95% CI, 1.326-3.254; P<0.001) compared to a small-sized vehicle. The group that did not wear a seat belt had more severe injuries than those who wore a seat belt (OR, 2.218; 95% CI, 1.421-3.463; P<0.001). 
		                        		
		                        			Conclusion
		                        			Injury severity was correlated with age, mode of transportation to the ED, type of collision and seat belt use. These results will help primary physicians assess critically ill patients. 
		                        		
		                        		
		                        		
		                        	
4.Use of succimer as an alternative antidote in copper sulfate poisoning: A case report
Sang Kyoon HAN ; Sung Wook PARK ; Young Mo CHO ; Il Jae WANG ; Byung Kwan BAE ; Seok Ran YEOM ; Soon Chang PARK
Journal of The Korean Society of Clinical Toxicology 2021;19(1):59-63
		                        		
		                        			
		                        			 Copper sulfate is widely used as a fungicide and pesticide. Acute copper sulfate poisoning is rare but potentially lethal in severe cases. Copper sulfate can lead to cellular damage of red blood cells, hepatocytes, and myocytes. Toxic effects include intravascular hemolysis, acute tubular necrosis and, rhabdomyolysis. A 76-year-old man presented with vomiting and epigastric pain. He had ingested a copper-containing fungicide (about 13.5 g of copper sulfate) while attempting suicide 2 hours prior to presentation. From day 3 at the hospital, laboratory findings suggesting intravascular hemolysis were noted with increased serum creatinine level. He was treated with a chelating agent, dimercaptosuccinic acid (succimer). His anemia and acute kidney injury gradually resolved with a 19-day regimen of succimer. Our case suggests that succimer can be used for copper sulfate poisoning when other chelating agents are not available. 
		                        		
		                        		
		                        		
		                        	
5.Feasibility of Laparoscopic Right Posterior Sectionectomy for Malignant Lesion Compared to Open Right Posterior Sectionectomy: Retrospective, Single Center Study
Eui Sung JEONG ; Yang Seok KOH ; Chol Kyoon CHO ; Hee Joon KIM ; Eun Kyu PARK
Journal of Minimally Invasive Surgery 2020;23(2):74-79
		                        		
		                        			 Purpose:
		                        			We aimed to compare the operative outcomes of laparoscopic right posterior sectionectomy (RPS) and open RPS and evaluate the feasibility of laparoscopic RPS. 
		                        		
		                        			Methods:
		                        			From January 2009 to December 2017, laparoscopic liver resections were performed in 235 patients at Chonnam National University Hwasun Hospital, South Korea. We retrospectively analyzed the clinical data of 16 patients who underwent laparoscopic RPS and compared the outcomes with those who underwent open RPS (n=17). 
		                        		
		                        			Results:
		                        			The laparoscopic group had a mean tumor size of 3.82±1.73 cm (open group [OG]; 4.18±2.07 cm, p=0.596), mean tumor-free margin of 10.44±9.69 mm (OG; 10.06±10.62 mm, p=0.657), mean operation time of 412.2±102.2 min (OG; 275.0±60.5, p<0.001), mean estimated blood loss of 339.4±248.3 ml (OG; 236.4±102.7 ml, p=0.631), mean postoperative hospital stay of 11.63±2.58 days (OG; 14.71±4.69 days, p=0.027), and mean postoperative peaks of aspartate aminotransferase, alanine aminotransferase, total bilirubin, and prothrombin time of 545 mg/dl, 538 mg/dl, 1.39 mg/dl, 1.41 international normalized ratio (OG; 237 (p<0.001), 216 (p<0.001), 1.52 (p=0.817), and 1.45 (p=0.468)), respectively. There were no deaths or major complications in ether group. There were no cases of open conversion. Laparoscopic RPS was associated with a shorter hospital stay, prolonged operation time and lower complication rate. With long-term prognosis, no difference was found in overall survival rate and disease-free survival rate between the two groups. 
		                        		
		                        			Conclusion
		                        			Laparoscopic RPS can be performed, but the problems of long operative time and decrease in liver function should be resolved. 
		                        		
		                        		
		                        		
		                        	
6.Synchronous Gastrointestinal Stromal Tumor and Ampullary Neuroendocrine Tumor in Association with Neurofibromatosis Type 1: A Report of Three Cases
Eun Kyu PARK ; Hee Joon KIM ; Yun Ho LEE ; Yang Seok KOH ; Young Hoe HUR ; Chol Kyoon CHO
The Korean Journal of Gastroenterology 2019;74(4):227-231
		                        		
		                        			
		                        			Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary disorder. The pathogenesis of NF1 is suggested to be an alteration of the NF-1 gene, which normally functions as a tumor suppressor. A mutation of NF-1 causes the development of viable tumors in various sites. On the other hand, the synchronous manifestation of a gastrointestinal stromal tumor (GIST) and neuroendocrine tumor (NET) in the background of NF1 is extremely rare. This paper reports three cases treated with surgical intervention along with the long-term follow-up results. Three patients showed synchronous ampullary NET and GIST in association with NF1 supported by postoperative histopathologic analysis. Surgical treatments, such as pancreatoduodenectomy and local excision were applied. No recurrence occurred during the postoperative follow-up period of 10, 9, and 2.7 years. Synchronous GIST and NET in the background of NF1 is extremely rare, but the possible coexistence of other tumors in NF1 patients is relatively higher than that in the general population. Furthermore, both NETs and GISTs occurring in NF1 patients tend to be smaller in size compared to that in the general population. Therefore, when NF1 patients present with vague abdominal discomfort, close attention must be paid to identifying the coexistence of other neoplasms.
		                        		
		                        		
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Gastrointestinal Stromal Tumors
		                        			;
		                        		
		                        			Hand
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Neuroendocrine Tumors
		                        			;
		                        		
		                        			Neurofibromatoses
		                        			;
		                        		
		                        			Neurofibromatosis 1
		                        			;
		                        		
		                        			Pancreaticoduodenectomy
		                        			;
		                        		
		                        			Recurrence
		                        			
		                        		
		                        	
7.G0/G1 Switch 2 Induces Cell Survival and Metastasis through Integrin-Mediated Signal Transduction in Human Invasive Breast Cancer Cells
Eunah CHO ; Yeo Jung KWON ; Dong Jin YE ; Hyoung Seok BAEK ; Tae Uk KWON ; Hyung Kyoon CHOI ; Young Jin CHUN
Biomolecules & Therapeutics 2019;27(6):591-602
		                        		
		                        			
		                        			Human breast cancer cell line, MDA-MB-231, is highly invasive and aggressive, compared to less invasive cell line, MCF-7. To explore the genes that might influence the malignancy of MDA-MB-231, DNA microarray analysis was performed. The results showed that G0/G1 switch 2 (G0S2) was one of the most highly expressed genes among the genes upregulated in MDA-MB-231. Although G0S2 acts as a direct inhibitor of adipose triglyceride lipase, action of G0S2 in cancer progression is not yet understood. To investigate whether G0S2 affects invasiveness of MDA-MB-231 cells, G0S2 expression was inhibited using siRNA, which led to decreased cell proliferation, migration, and invasion of MDA-MB-231 cells. Consequently, G0S2 inhibition inactivated integrin-regulated FAK-Src signaling, which promoted Hippo signaling and inactivated ERK1/2 signaling. In addition, G0S2 downregulation decreased β-catenin expression, while E-cadherin expression was increased. It was demonstrated for the first time that G0S2 mediates the Hippo pathway and induces epithelial to mesenchymal transition (EMT). Taken together, our results suggest that G0S2 is a major factor contributing to cell survival and metastasis of MDA-MB-231 cells.
		                        		
		                        		
		                        		
		                        			Breast Neoplasms
		                        			;
		                        		
		                        			Breast
		                        			;
		                        		
		                        			Cadherins
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Cell Proliferation
		                        			;
		                        		
		                        			Cell Survival
		                        			;
		                        		
		                        			Down-Regulation
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lipase
		                        			;
		                        		
		                        			Neoplasm Metastasis
		                        			;
		                        		
		                        			Oligonucleotide Array Sequence Analysis
		                        			;
		                        		
		                        			RNA, Small Interfering
		                        			;
		                        		
		                        			Signal Transduction
		                        			
		                        		
		                        	
8.Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database
Yunghun YOU ; Jin Young JANG ; Song Cheol KIM ; Yoo Seok YOON ; Joon Seong PARK ; Chol Kyoon CHO ; Sang Jae PARK ; Jae Do YANG ; Woo Jung LEE ; Tae Ho HONG ; Keun Soo AHN ; Chi Young JEONG ; Hyeon Kook LEE ; Seung Eun LEE ; Young Hoon ROH ; Hee Joon KIM ; Hongbeom KIM ; In Woong HAN
Cancer Research and Treatment 2019;51(4):1639-1652
		                        		
		                        			
		                        			PURPOSE: The 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic neuroendocrine tumor (PNET) included several significant changes. We aim to evaluate this staging system compared to the 7th edition AJCC staging system and European Neuroendocrine Tumors Society (ENETS) system. MATERIALS AND METHODS: We used Korean nationwide surgery database (2000-2014). Of 972 patients who had undergone surgery for PNET, excluding patients diagnosed with ENETS/World Health Organization 2010 grade 3 (G3), only 472 patients with accurate stage were included. RESULTS: Poor discrimination in overall survival rate (OSR) was noted between AJCC 8th stage III and IV (p=0.180). The disease-free survival (DFS) curves of 8th AJCC classification were well separated between all stages. Compared with stage I, the hazard ratio of II, III, and IV was 3.808, 13.928, and 30.618, respectively (p=0.007, p < 0.001, and p < 0.001). The curves of OSR and DFS of certain prognostic group in AJCC 7th and ENETS overlapped. In ENETS staging system, no significant difference in DFS between stage IIB versus IIIA (p=0.909) and IIIA versus IIIB (p=0.291). In multivariable analysis, lymphovascular invasion (p=0.002), perineural invasion (p=0.003), and grade (p < 0.001) were identified as independent prognostic factors for DFS. CONCLUSION: This is the first large-scale validation of the AJCC 8th edition staging system for PNET. The revised 8th system provides better discrimination compared to that of the 7th edition and ENETS TNM system. This supports the clinical use of the system.
		                        		
		                        		
		                        		
		                        			Classification
		                        			;
		                        		
		                        			Discrimination (Psychology)
		                        			;
		                        		
		                        			Disease-Free Survival
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Joints
		                        			;
		                        		
		                        			Neoplasm Staging
		                        			;
		                        		
		                        			Neuroectodermal Tumors, Primitive
		                        			;
		                        		
		                        			Neuroendocrine Tumors
		                        			;
		                        		
		                        			Pancreas
		                        			;
		                        		
		                        			Survival Rate
		                        			
		                        		
		                        	
9.Synchronous Gastrointestinal Stromal Tumor and Ampullary Neuroendocrine Tumor in Association with Neurofibromatosis Type 1: A Report of Three Cases
Eun Kyu PARK ; Hee Joon KIM ; Yun Ho LEE ; Yang Seok KOH ; Young Hoe HUR ; Chol Kyoon CHO
The Korean Journal of Gastroenterology 2019;74(4):227-231
		                        		
		                        			
		                        			Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary disorder. The pathogenesis of NF1 is suggested to be an alteration of the NF-1 gene, which normally functions as a tumor suppressor. A mutation of NF-1 causes the development of viable tumors in various sites. On the other hand, the synchronous manifestation of a gastrointestinal stromal tumor (GIST) and neuroendocrine tumor (NET) in the background of NF1 is extremely rare. This paper reports three cases treated with surgical intervention along with the long-term follow-up results. Three patients showed synchronous ampullary NET and GIST in association with NF1 supported by postoperative histopathologic analysis. Surgical treatments, such as pancreatoduodenectomy and local excision were applied. No recurrence occurred during the postoperative follow-up period of 10, 9, and 2.7 years. Synchronous GIST and NET in the background of NF1 is extremely rare, but the possible coexistence of other tumors in NF1 patients is relatively higher than that in the general population. Furthermore, both NETs and GISTs occurring in NF1 patients tend to be smaller in size compared to that in the general population. Therefore, when NF1 patients present with vague abdominal discomfort, close attention must be paid to identifying the coexistence of other neoplasms.
		                        		
		                        		
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Gastrointestinal Stromal Tumors
		                        			;
		                        		
		                        			Hand
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Neuroendocrine Tumors
		                        			;
		                        		
		                        			Neurofibromatoses
		                        			;
		                        		
		                        			Neurofibromatosis 1
		                        			;
		                        		
		                        			Pancreaticoduodenectomy
		                        			;
		                        		
		                        			Recurrence
		                        			
		                        		
		                        	
10.The Usefulness of the mPTS (modified pediatric trauma score) and Newly Developed Extended mPTS as a High Risk Pediatric Trauma Patients Screening Tool: Support of Two Tiered Trauma Team Activation System.
Moon Cheol KANG ; Il Jae WANG ; Suck Ju CHO ; Seok Ran YEOM ; Sang Kyoon HAN ; Sung Wook PARK ; Seong Hwa LEE ; Soon Chang PARK ; Dae Sup LEE ; Hyun Min CHO
Journal of the Korean Society of Emergency Medicine 2017;28(6):579-586
		                        		
		                        			
		                        			PURPOSE: A secondary triage tool for pediatric trauma patients, “modified pediatric trauma score (mPTS)” was introduced to predict high risk trauma. METHODS: Pediatric trauma patients (≤15 years) presenting to the Pusan National University Hospital trauma center emergency department were analyzed retrospectively. The patients were classified into high risk and low risk groups. The high risk group was assigned an Injury Severity Score ≥12, death, intensive care unit admission, or urgent intervention (intubation, closed thoracostomy, emergency angiography and embolization, emergency surgery). The airway, blood pressure, fractures, level of consciousness, and external wounds were evaluated and the mPTS was calculated. RESULTS: One hundred seventy-seven patients were enrolled in this study. The mPTS had a sensitivity, specificity, positive predictive value, and negative predictive value of 88%, 54%, 60%, and 85%, respectively. Overtriage and undertriage was 39% and 14%, respectively. The mPTS missed 6 high risk patients and all 6 patients were abdominal injury patients. The mPTS was modified to include an abdominal physical examination and/or focused assessment with sonography for trauma. The newly developed scoring system was called the extended mPTS (E-mPTS). The E-mPTS had a sensitivity of 98% and negative predictive value of 98%. The safe level of overtriage (38%) was maintained. CONCLUSION: mPTS was applied to the patients and the undertriage rate was too high. The extended mPTS improved undertriage to 2% while maintaining the overtriage rate at a safe level. The E-mPTS is expected to have a resource saving effect when used as a pediatric trauma team activation standard.
		                        		
		                        		
		                        		
		                        			Abdominal Injuries
		                        			;
		                        		
		                        			Angiography
		                        			;
		                        		
		                        			Blood Pressure
		                        			;
		                        		
		                        			Busan
		                        			;
		                        		
		                        			Consciousness
		                        			;
		                        		
		                        			Emergencies
		                        			;
		                        		
		                        			Emergency Medicine
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Injury Severity Score
		                        			;
		                        		
		                        			Intensive Care Units
		                        			;
		                        		
		                        			Mass Screening*
		                        			;
		                        		
		                        			Pediatrics
		                        			;
		                        		
		                        			Physical Examination
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Sensitivity and Specificity
		                        			;
		                        		
		                        			Thoracostomy
		                        			;
		                        		
		                        			Trauma Centers
		                        			;
		                        		
		                        			Triage
		                        			;
		                        		
		                        			Wounds and Injuries
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail